.jpg?format=webp&width=780)
Limited information exists regarding the effects of prostate cancer therapies on sexual health outcomes in sexual and gender minority patients. As clinicians, scientists and advocates, understanding these outcomes is imperative in order to enable personalized clinical decision-making and to create a more equitable health system. In prostate cancer, the effects of therapies on sexual outcomes in sexual and gender minority (SGM) patients are an under-represented area of research. How the prostate functions as a sexual organ in receptive anal intercourse, how treatments affect sexual health in SGM patients, and how to counsel a diverse range of patients with prostate cancer on treatment.
Like
Save
Share